Available Screened Surrogates

Our surrogate mothers undergo prenatal care and give birth at hospitals in their home state, where our case managers follow up on their prenatal care and report back to our doctors. This means that two teams of medical professionals from different hospitals are watching over your child's health. Additionally, our case managers provide regular updates on your child's growth and ensure the proper care of your surrogate mother's physical and emotional health, ensuring that your child is born into a loving and nurturing environment. Our comprehensive prenatal care includes:

1.First-Trimester Screening Blood Test

First-Trimester Screening Blood Test，Performed at 10–14 weeks. Since first-trimester screening can be done earlier than most other tests, you’ll have the results early in the pregnancy. This will give you more time to decide whether or not further testing is needed, map out a plan for the rest of the pregnancy, and get any medical treatment if needed. This test offers early information about a baby’s risk of 

Down Syndrome (trisomy 21) and extra sequences of chromosome 18 (trisomy 18). 

2.NIPT

A prenatal screening looks at DNA from your baby’s placenta through a sample of your Surrogate’s blood, Performed at 9–13 weeks. This test is used to identify whether she’s at an increased risk of giving birth to a child with a genetic disorder. However, NIPT cannot definitively determine whether your baby has a chromosomal disorder, only the likelihood of having a certain condition. 

While an NIPT test can’t tell for sure whether your baby has a genetic abnormality, it’s highly accurate. It’s 97 to 99 percent accurate for detecting the following common conditions:

• Down Syndrome

• Trisomy 18

• Spina bifida

Since surrogate mothers only provide a place for the baby to grow and do not contribute any genetic material, genetic factors are determined by the source of your sperm and eggs. Before creating embryos, we conduct CGT genetic disease testing to ensure that there are no shared recessive genetic diseases between the sperm and egg. After the formation of embryos, PGS genetic screening accurately eliminates embryos with chromosomal abnormalities. We only use healthy embryos that have passed PGS screening for surrogate’s implantation. If there are known genetic diseases in your family, we also conduct PGD embryo preimplantation genetic diagnosis to eliminate them in advance.

3.NT Sonogram 

Performed at 10–14 weeks. The nuchal translucency scan (also called an NT scan) uses ultrasound to assess your developing baby’s risk of having Down Syndrome (DS-trisomy 21), congenital heart problems, and other chromosomal abnormalities.Other conditions may include: Patau (trisomy 13) and Edwards (trisomy 18) syndromes. These are rare and often fatal chromosomal abnormalities. The test is typically performed alongside the First Trimester Screening blood test.

4.AFP Quad Screen

Performed at 15-20 weeks. A maternal blood screen that is similar to the Triple Screen Test (also known as AFP Plus and the Multiple Marker Screening). However, the quad screen looks for not only AFP, hCG, and Estriol, but a fourth substance known as Inhibin-A.

A quad screen is used to evaluate whether the baby has an increased chance of having Down Syndrome or neural tube defects. The test also identifies the following: Trisomy 18, Spina bifida

and Abdominal wall defects.

5.Fetal Echocardiogram

Performed at 18–24 weeks. This test is recommended in all IVF/ICSI pregnancies in accordance with recent American Heart Association practice guidelines. Testing will improve prenatal diagnosis, management, and referral of the affected pregnancies for delivery and prenatal/postnatal interventio ns, with the goal of improving outcomes.This test is typically performed by a specially trained ultrasound sonographer and the images are interpreted by a pediatric cardiologist who specializes in fetal congenital heart disease. Some maternal-fetal medicine specialists (Perinatologist) also perform fetal echocardiograms.